Having established that iRGD-targeted delivery of siRNA can lead to receptor- and sequence-specific suppression of TNFα gene expression in an NF2-derived vestibular schwannoma cell line, we then evaluated the ability of iRGD nanoparticles to mediate RNAi in primary human VS cultures. This evidence concerns the gene NF2 and Vestibular schwannoma.